pantoprazole has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 5.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| " pylori eradication rate with a standard triple therapy regardless of the regimen utilized, the dosage and/or the duration of the therapy used appearing not to be sufficient to eradicate the infection efficiently." | 2.69 | Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. ( Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG, 2000) |
| "Childhood-onset type 1 diabetes mellitus (DM) is a common chronic metabolic disease associated with life-threatening complications." | 1.91 | Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis. ( Goncu, S; Kiremitci, S; Mengen, E; Tas, N; Tasar, S; Ucakturk, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tas, N | 1 |
| Mengen, E | 1 |
| Goncu, S | 1 |
| Tasar, S | 1 |
| Kiremitci, S | 1 |
| Ucakturk, A | 1 |
| Gasbarrini, A | 1 |
| Ojetti, V | 1 |
| Pitocco, D | 1 |
| Armuzzi, A | 1 |
| Silveri, NG | 1 |
| Pola, P | 1 |
| Ghirlanda, G | 1 |
| Gasbarrini, G | 1 |
1 trial available for pantoprazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bism | 2000 |
1 other study available for pantoprazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Pantoprazole Induced Acute Interstitial Nephritis in a Patient with Diabetic Ketoacidosis.
Topics: Acute Disease; Child; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Humans; Pancreatitis; Pantop | 2023 |